top of page
Alzheimers Web Header.png

Alzheimer's Disease

This clinical trial is now CLOSED

Current therapies for Alzheimer's may provide symptomatic relief from cognitive difficulties however, they only produce a modest effect and are accompanied by dose-limiting side effects, such as nausea, vomiting, diarrhoea, muscle cramps and general malaise.

This study will investigate if the early intervention with a new medication can help to prevent the condition from deteriorating.

 

Are you currently aged between 50-90?

Have Been diagnosed with mild to moderate Alzheimer's disease​?

If you have answered YES to the questions above, you may be eligible to be part of a new trial being held in Christchurch.​ This trial will investigate if the early administration of the investigative product can help to prevent the condition from deteriorating.

If you're interested in learning more about the study, please fill out the form below or call us on 03 365 6777

Alzheimers Web Header.png
bottom of page